The United States Army Medical Research Institute for Infectious Diseases (USAMRIID) employs a range of advanced technologies to address biological threats and emerging diseases. Their research encompasses various fields, including bacteriology, virology, and molecular biology, focusing on the prevention and treatment of diseases caused by bacterial and viral agents. USAMRIID's work includes the development of novel vaccines and therapeutics, as well as the creation of diagnostic systems that enhance the laboratory diagnosis of infectious diseases. They utilize systems-based omics technologies to analyze host-pathogen interactions and improve medical countermeasures, alongside high-throughput screening and imaging techniques to support drug discovery.

Additionally, USAMRIID is actively engaged in technology transfer and collaboration with external partners, including academia and industry, to facilitate the development of medical countermeasures. They employ mechanisms such as Cooperative Research and Development Agreements (CRADAs) and Material Transfer Agreements (MTAs) to foster innovation and share resources. Their commitment to advancing medical biological defense is evident in their ongoing research efforts, which aim to protect military personnel and the nation from biological threats through cutting-edge scientific advancements.

United States

Since its inception in 1969, USAMRIID has spearheaded research to develop medical solutions, vaccines, drugs, diagnostics, and information to protect military service members from biological threats. Its specialized capabilities include Biosafety Level 3 and Level 4 laboratories, world-class expertise in the generation of biological aerosols for testing candidate vaccines and therapeutics, and fully accredited animal research facilities.

United States Army Medical Research Institute for Infectious Diseases

Company Details